Wikidata

(Q67983004)

English

The antiemetic efficacy and the cost-benefit ratio of ondansetron calculated with a new approach to health technology assessment (real cost-benefit index)

scientific article published on 01 October 1992

In more languages
default for all languages
No label defined

No description defined

Statements

title
The antiemetic efficacy and the cost-benefit ratio of ondansetron calculated with a new approach to health technology assessment (real cost-benefit index) (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
1479424
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1479424%20AND%20SRC:MED&resulttype=core&format=json
retrieved
20 September 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q67983004&oldid=1892632866"